HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion

Clinical trial NCT07699757 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07699757
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Pancreatic Ductal Adenocarcinoma (mPDAC)Advanced Solid Tumors

Start date: 2026-07-01
Primary completion: 2029-04-01
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.